The changes of plasma malondialdehyde, nitric oxide, and adrenomedullin levels in patients with preeclampsia oxidative stress in preeclampsia

Hypertension in Pregnancy

Volumn 28, Issue 4, 2009, Pages 383-389

  Dikensoy, Ebru ^a   Balat, Ozcan ^a   Pence, Sadrettin ^a   Balat, Ayse ^a   Cekmen, Mustafa ^b   Yurekli, Muhuttin ^c  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b KOCAELI UNIVERSITY   (Turkey)

^c Inn University   (Turkey)

Author keywords

Adrenomedullin; Malondialdehyde.; Nitric oxide; Preeclampsia

Indexed keywords

ADRENOMEDULLIN; MALONALDEHYDE; NITRIC OXIDE; NITRITE;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID PEROXIDATION; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PREECLAMPSIA; VASODILATATION;

ADRENOMEDULLIN; FEMALE; HUMANS; MALONDIALDEHYDE; NITRIC OXIDE; PATIENT SELECTION; PRE-ECLAMPSIA; PREGNANCY;

EID: 70350309504     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950802629634     Document Type: Article

References (26)

1. Cunningham FG, Lindheimer MD. Hypertension in pregnancy. N Eng J Med 1992; 326:927-932.
2. Redman CWG.The Placenta, preeclampsia and chronic villitis. In: Redman CWG, Sargent IL, Starkey PM, eds. The Human Placenta. London, England: Blackwell Scientific Publications; 1993:433-467.
3. Hayman R, Brockelsby J, Kenny L, Baker P. Preeclampsia: the endothelium, circulating factor(s) and vascular endothelial growth factor. J Soc Gynecol Invest 1999; 6:3-10.
4. Roberts J. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998; 16:5-15.
5. Roberts JM. Pregnancy related hypertension. In: Creasy RK, Resnik R, eds. Maternal Fetal Medicine: Principles and Practise. Philadelphia: W.B. Saunders, 1989.
6. Mohaupt M. Molecular aspects of preeclampsia. Mol Aspects Med 2007; 28:169-191.
7. Lowe DT. Nitric oxide dysfunction in the pathophysiology of preeclampsia. Nitric Oxide 2000; 4:441-448.
8. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192:553-560.
9. Jerat S, Morrish DW, Davidge ST, Kaufman S. Effect of adrenomedullin on placental arteries in normal and preeclamptic pregnancies. Hypertension 2001; 37:227-231.
10. National High Blood Pressure Education Program Working on High Blood Pressure in Pregnancy.Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 2000; 183:1-22.
11. Wilcox MA, Jhonson IR, Maynard PV, Smith SJ, Chilvers CED.The individualized birthweight ratio: a more logical outcome measure of pregnancy than birthweight alone. Br J Obstet Gynaecol 1993; 100:342-347.
12. Buege JA, Aust SD. Microsomal lipid peroxidation. Meth Enzymol 1978; 52:302-310.
13. Roberts JM, Cooper DW. Pathogenesis and genetics of preeclampsia. Lancet 2001; 357:53-56.
14. Kauma S, Takacs P, Scordalakes C, Walsh S. Increased endothelial monocyte chemoattractant protein-1 and interleukin-8 in preeclampsia. Obstet Gynecol 2002; 100:706-714.
15. Serdar Z, Gur E, Develioglu O, Colakogullari M. Placental and desidual lipid peroxidation and antioxidant defenses in preeclampsia lipid peroxidation in preecclampsia. Pathophysiology 2002; 9:21-25.
16. Kumar CA, Das UN. Lipid peroxides, antioxidants and nitric oxide in patients with preeclampsia and essential hypertension. Med Sci Monit 2000; 6:901-907.
17. Sikkema JM, Van Rijn BB, Franx A, et al. Placental superoxide is increased in preeclampsia. Placenta 2001; 22:304-308.
18. Vane JR, Botting RM. Regulatory functions of the vascular endothelium. N Eng J Med 1990; 323:27-36.
19. Vane JR, Botting RM. The role of chemical mediators released by the endothelium in the control of the cardiovascular system. Int J Tissue React 1992; 14: 55-64.
20. Inoue M, Nishikawa M, Sato EE. Cross talk of NO, superoxide and molecular oxygen, a majesty of aerobic life. Free Rad Res 1999; 31:251-261.
21. Vatish M, Harpal SR, Grammatopoulos KD. Hormonal regulation of placental nitric oxide and pathogenesis of preeclampsia. Trends Mol Med 2006; 12:223-233.
22. Kilicdag EB, Ay G, Çelik A, Ustundag B. Oxidant-antioxidant system changes relative to placental-umbilical pathology in patients with preeclampsia. Hypertens Preg 2005; 24:147-157.
23. Jaugasaki M, Wei CM, Aarhus LL. Renal localization and actions of adrenomedullin: a natriuretic peptide. Am J Physiol 1995; 268:657-663.
24. Parkes DG. Cardivascular actions of adrenomedullin in conscious sheep. Am J Physiol 1995; 268:2574-2578.
25. Kato J, Kitamura K, Kangawa K, Eto T. Receptors for adrenomedullin in human vascular endothelial cells. Eur J Pharmacol 1995; 289:383-385.
26. Jerat S, Donald WM, Davidge ST, Kaufman S. Effect of adrenomedullin on placental arteries in normal and preeclamptic pregnancies. Hypertension 2001; 37:227-231.